Rohto Pharmaceutical Co.,Ltd. (4527.T) JPX

Currency In JPY

AD

Valuation

Market Cap544.01B
Enterprise Value517.44B
P/E Ratio15.52
PEG Ratio1.39
Price/Sales Ratio1.55
Price/Book Ratio1.76
Enterprise/Revenue1.47
Enterprise/EBITDA7.71

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.1
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.12

Income Statement

Revenue343.73B
Revenue/Share1,520.89
Gross Profit182.96B
EBITDA65.48B
Net Income34.25B
Diluted EPS145.29

Balance Sheet

Total Cash86.82B
Total Cash/Share384.14
Total Debt60.24B
Total Debt/Equity0.2
Current Ratio2.04
Book Value Per Share1,416.7

Price History

52-Week Change9.57
52-Week High2,703
52-Week Low2,134
Moving Average 50 Days2,404.17
Moving Average 200 Days2,454.75

Statistics

Average Volume982,313
Shares Outstanding225.96M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate46
Trailing Annual Dividend Yield1.96
Payout Ratio0
Last Split Factor2:1
Last Split DateDecember 29, 2022
AD